“Translational Research in Autism Spectrum Disorders”
Wednesday, Apr. 6, 12:00-1:00 p.m.
Room 241, Vanderbilt Kennedy Center/One Magnolia Circle
This panel will feature emerging multidisciplinary lines of research at Vanderbilt on the pathophysiology and treatment of autism spectrum disorders. Presentations will: (a) provide an overview of the research goals and challenges in this area, (b) describe research methods and findings across a range of preclinical models, and (c) describe challenges in clinical treatment outcome measurement and a novel approach for addressing these challenges.
List of talks:
- "The Translational Research Pipeline' for Treatment Development in Autism: Promises and Pitfalls"
Jim Bodfish, Ph.D., Department of Hearing & Speech Sciences
- "Development of a Novel ASD Mouse Model from Genetic Studies"
Jason Stephenson, Ph.D., Colbran Lab – Department of Molecular Physiology and Biophysics
- "Functional and Behavioral Characterization of a Rare, Autism-Associated Dopamine Transporter Variant"
Aparna Shekar, Galli Lab – Molecular Physiology and Biophysics
- "Applications of Direct Behavior-Analytic Assessments to Evaluate Effects of Psychotropic Medications for Children with Developmental Disorders"
Blair Lloyd, Ph.D., Department of Special Education
This unique new educational series will focus on the complexities of conducting interdisciplinary research and clinical trials that involve behavioral, environmental, and pharmaceutical interventions. The series aims to promote cross-talk among behavioral/educational and biomedical researchers with the long-term goal of developing multimodal treatments for individuals with intellectual and developmental disabilities (IDD), including learning
disabilities, genetic syndromes, and autism spectrum disorder.
This series is intended for clinicians, researchers, trainees, and students. Community members welcome.
Info: email@example.com or 322-8240
Co-Sponsors • Vanderbilt Kennedy Center • Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center • University Center for Excellence in Developmental Disabilities • Leadership Education in Neurodevelopmental and Related Disabilities Training Program • Treatment and Research Institute for Autism Spectrum Disorders • Vanderbilt Institute for Clinical and Translational Research
Accreditation: Vanderbilt School of Medicine is accredited by
the Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.
CME Credit: Vanderbilt School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
APA Credit: Vanderbilt School of Medicine is approved
by the American Psychological Association to sponsor continuing education for
psychologists. Vanderbilt School of Medicine maintains responsibility for this
program and its content. Vanderbilt School of Medicine designates this
educational activity for 1.0 CE credits toward the continuing education of
psychologists. No partial credit may be awarded.
Disclosure: It is the policy of Vanderbilt School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.
Support: This educational activity received no commercial
Obtaining CME Credit for this event: Physicians and
psychologists may obtain credit by signing the attendance log; attendance and
credit data will be stored in the CME database and may be accessed through the
Vanderbilt CME database. (http://cme.vanderbilt.edu/)